(Natural News) Insys Therapeutics of Chandler, Arizona, is reportedly having to fork out $225 million in fines to the federal government for bribing doctors to prescribe as much fentanyl and other opiates as they could get away with – including to patients who didn’t even need them.
Described as the “driving force” behind America’s ongoing opioid epidemic, the shady “distribution scheme” hatched by Insys involved contracting with doctors to illicitly prescribe opioids in exchange for high-paying “sham speeches” – a pay-for-play trafficking conspiracy, in other words, that’s made pill-pushing doctors and Insys obscenely wealthy.
Under the guise of giving “educational” talks, the corrupt doctors that partnered with Insys were basically just getting big paychecks for prescribing large amounts of Sybsys, the brand-name fentanyl drug marketed by Insys for pain.
As you may recall, Insys founder and billionaire pharmacist John Kapoor was arrested and charged with racketeering and other conspiracy crimes back in 2017, all stemming from the company’s opioid scams. He and other Insys executives are now facing up to 20 years in prison for their crimes.
“A degree of public accountability being levied against Insys could spur the American public to demand criminal proceedings against other pioneers of the nation’s opioid crisis, most prominently among them the billionaire oligarch Sackler family,” writes Richard Moorhead for Big League Politics, the Sackler family being the pharma peddlers behind OxyContin (oxycodone), another deadly opioid drug.
|Discover how to prevent and reverse heart disease (and other cardio related events) with this free ebook: Written by popular Natural News writer Vicki Batt, this book includes everything you need to know about preventing heart disease, reversing hypertension, and nurturing your cardiac health without medication. Learn More.|
“The Sacklers, one of America’s wealthiest families, developed and popularized a new generation of opioid-based painkillers, misrepresenting the potential dangers their products posed to the public and profiting off of them to the tunes of billions of dollars,” he adds.
Insys is the same corrupt pharma company manufacturing fake cannabis with the DEA’s blessing
If the name Insys sounds familiar, it’s probably because this is the same pharmaceutical corporation that colluded with the United States Food and Drug Administration (FDA) to market and sell a synthetic cannabis rip-off drug at the same time that real, all-natural cannabis remains a prohibited, Schedule I “drug” with “no currently accepted medical use and a high potential for abuse.”
In other words, corruption runs deep at Insys – and all throughout the Big Pharma criminal racket, for that matter. Truth be told, there’s next to nothing peddled by the pharmaceutical cartels that doesn’t have a better and safer counterpart offered for free by nature.
If only more Americans knew and accepted this fact, then we could finally put an end to the opioid epidemic. Heck, we could end pharmaceutical addiction entirely if all healing plants were removed from the Drug Enforcement Administration’s (DEA) unconstitutional schedules and given back to We the People where they belong.
One can dream, anyway. But at least the Big Pharma house of cards is finally starting to collapse, which means that one by one, like dominoes, the criminal pharma cartels will go down as the wheels of justice make their slow but persistent turn – with Insys being just the beginning.
“For the malevolent pharmaceutical kingpins of Insys, a life sentence in the nation’s prison system is little more than a slap on the hand in the eyes of the millions of Americans who have lost a family member or loved one to the ongoing scourge of opiate addiction,” is Moorhead’s take on the situation.
For more stories about how the government working on behalf of Big Pharma interests is unconstitutional tyranny against We the People, be sure to check out Tyranny.news.
You can also learn more about how to take care of yourself without the need for pharmaceuticals at NaturalMedicine.news.
Sources for this article include: